Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Population Science
Concomitant Mitral Regurgitation in Severe Aortic Stenosis ― A Report From the CURRENT AS Registry ―
Ryosuke MuraiYuichi KawaseTomohiko TaniguchiTakeshi MorimotoKazushige KadotaMasanobu OhyaTakenobu ShimadaTakeshi MaruoYasushi FukuTatsuhiko KomiyaKenji AndoMichiya HanyuNorio KanamoriTakeshi AoyamaKoichiro MurataTomoya OnoderaFumio YamazakiTakeshi KitaiYutaka FurukawaTadaaki KoyamaMakoto MiyakeChisato IzumiYoshihisa NakagawaKazuo YamanakaHirokazu MitsuokaManabu ShirotaniMasashi KatoShinji MikiHiroyuki NakajimaYutaka HiranoShunichi MiyazakiToshihiko SagaSachiko SugiokaShintaro MatsudaMitsuo MatsudaTatsuya OgawaKazuya NagaoTsukasa InadaShogo NakayamaHiroshi MabuchiYasuyo TakeuchiHiroki SakamotoGenichi SakaguchiKeiichiro YamaneHiroshi EizawaMamoru ToyofukuTakashi TamuraAtsushi IwakuraMitsuru IshiiMasaharu AkaoKotaro ShiragaEri Minamino-MutaTakao KatoMoriaki InokoKoji UeyamaTomoyuki IkedaYoshihiro HimuraAkihiro KomasaKatsuhisa IshiiKozo HottaYukihito SatoKeiichi FujiwaraYoshihiro KatoIchiro KouchiYasutaka InuzukaShigeru IkeguchiSenri MiwaChiyo MaedaEiji ShinodaJunichiro NishizawaToshikazu JinnaiNobuya HigashitaniMitsuru KitanoYuko MorikamiShouji KitaguchiKenji MinatoyaTakeshi Kimuraon behalf of the CURRENT AS Registry Investigators
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2022 Volume 86 Issue 3 Pages 427-437

Details
Abstract

Background:The clinical significance of concomitant mitral regurgitation (MR) has not been well addressed in patients with severe aortic stenosis (AS).

Methods and Results:We analyzed 3,815 patients from a retrospective multicenter registry of severe AS in Japan (CURRENT AS registry). We compared the clinical outcomes between patients with moderate/severe MR and with none/mild MR according to the initial treatment strategy (initial aortic valve replacement [AVR] or conservative strategy). The primary outcome measure was a composite of aortic valve-related death or heart failure hospitalization. At baseline, moderate/severe MR was present in 227/1,197 (19%) patients with initial AVR strategy and in 536/2,618 (20%) patients with a conservative strategy. The crude cumulative 5-year incidence of the primary outcome measure was significantly higher in patients with moderate/severe MR than in those with none/mild MR, regardless of the initial treatment strategy (25.2% vs. 14.4%, P<0.001 in the initial AVR strategy, and 63.3% vs. 40.7%, P<0.001 in the conservative strategy). After adjusting confounders, moderate/severe MR was not independently associated with higher risk for the primary outcome measure in the initial AVR strategy (hazard ratio [HR] 1.11, 95% confidence interval [CI] 0.67–1.83, P=0.69), and in the conservative strategy (HR 1.13, 95% CI 0.93–1.37, P=0.22).

Conclusions:Concomitant moderate/severe MR was not independently associated with higher risk for the primary outcome measure regardless of the initial treatment strategy.

Content from these authors
© 2022, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top